News tagged with journal of experimental medicine
Related topics: protein , cells , t cells , tumor , immune cells
Experimental pill may ease multiple sclerosis disability
(HealthDay) -- Yet another orally taken medication shows some promise in preventing relapse and disability for people with relapsing-remitting multiple sclerosis, a new report suggests.
Diseases, Conditions, Syndromes
Mar 14, 2012 |
5 / 5 (2) |
0
|
Gene known to protect against cancer can also promote tumor growth: study
Can a gene simultaneously protect against cancer and favor its growth? Researchers at the Spanish National Cancer Research Centre have discovered a gene with this double-edged property and suspect there may be many more that ...
Cancer
Mar 13, 2012 |
5 / 5 (1) |
0
Lasting T cell memories
The generation of new memories in the human immune system doesn't come at the cost of old ones, according to a study published on March 5th in the Journal of Experimental Medicine.
Immunology
Mar 05, 2012 |
5 / 5 (1) |
0
A culprit behind brain tumor resistance to therapy
Persistent protein expression may explain why tumors return after therapy in glioblastoma patients, according to a study published on March 5th in the Journal of Experimental Medicine.
Cancer
Mar 05, 2012 |
not rated yet |
0
How autoreactive T cells slip through the cracks
Immune cells capable of attacking healthy organs "see" their targets differently than do protective immune cells that attack viruses, according to work published online this week in the Journal of Experimental Medicine.
Medical research
Feb 06, 2012 |
5 / 5 (1) |
0
Selectively inhibiting PKM2 starves cancer cells
Crippling a protein that allows cancer cells to grow when oxygen is scarce causes tumors to regress, according to a study published online on January 23 in the Journal of Experimental Medicine.
Cancer
Jan 23, 2012 |
not rated yet |
0
A single therapy slows multiple cancers
Targeting a single protein can help fight both breast cancers and leukemias, according to two reports published online on January 23 in the Journal of Experimental Medicine.
Cancer
Jan 23, 2012 |
5 / 5 (1) |
0
Genetic diversity: Crucial for our survival in many ways
(Medical Xpress) -- Thanks to the sequencing of the 27 known human interferon genes, researchers from the Institut Pasteur and the CNRS reconstruct the genetic history of these proteins so central for our immune system, and ...
Genetics
Dec 20, 2011 |
4 / 5 (1) |
0
Innovative new strategy to treat Parkinson's disease
Stabilizing the cell's power-generating center protects against Parkinson's disease (PD) in a rat model, according to a report published online this week in the Journal of Experimental Medicine.
Medical research
Dec 19, 2011 |
not rated yet |
0
Two-faced leukemia?
One kind of leukemia sometimes masquerades as another, according to a study published online this week in the Journal of Experimental Medicine.
Cancer
Dec 12, 2011 |
5 / 5 (4) |
0
How brain tumors invade
Scientists have pinpointed a protein that allows brains tumors to invade healthy brain tissue, according to work published this week in the Journal of Experimental Medicine.
Cancer
Dec 12, 2011 |
5 / 5 (1) |
0
Traumatic injury sets off a 'genomic storm' in immune system pathways
Serious traumatic injuries, including major burns, set off a "genomic storm" in human immune cells, altering around 80 percent of the cells' normal gene expression patterns. In a report to appear in the December Journal of ...
Medical research
Dec 07, 2011 |
5 / 5 (1) |
1
|
What wakes dormant tumor cells
Prostate tumor cells can be lulled to sleep by a factor released by bone cells, according to a study published online this week in the Journal of Experimental Medicine. Disease recurs in up to half of prostate cancer patien ...
Cancer
Nov 28, 2011 |
not rated yet |
0
Potential new drug target in Lou Gehrig's disease
Two proteins conspire to promote a lethal neurological disease, according to a study published online this week in the Journal of Experimental Medicine.
Diseases, Conditions, Syndromes
Nov 14, 2011 |
not rated yet |
0
Experimental vaccine protects monkeys from blinding trachoma
An attenuated, or weakened, strain of Chlamydia trachomatis bacteria can be used as a vaccine to prevent or reduce the severity of trachoma, the world's leading cause of infectious blindness, suggest findings from a Nati ...
Diseases, Conditions, Syndromes
Oct 10, 2011 |
not rated yet |
0
|
